BCL2L11 and cancer: We concluded that BCL2L11, E2F2, FOXP1, HMOX1, ITGA5, MIR34A, MARCKS, ZEB1, THBS1, TIMP3, VIM, and RPS6KA5 were enriched in the microRNAs in cancer pathway.